Lantheus Holdings (LNTH) EBT Margin Growth (1y) (2015 - 2026)
Lantheus Holdings (LNTH) EBT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | -348.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -348.00 |
| Mar 31, 2026 | 1,555.00 |
| Dec 31, 2025 | 12,901.00 |
| Sep 30, 2025 | -3,547.00 |
| Jun 30, 2025 | 624.00 |
| Mar 31, 2025 | -2,040.00 |
| Dec 31, 2024 | -103,280.00 |
| Sep 30, 2024 | -349.00 |
| Jun 30, 2024 | -1,704.00 |
| Mar 31, 2024 | 4,998.00 |
| Dec 31, 2023 | 98,966.00 |
| Sep 30, 2023 | 1,530.00 |
| Jun 30, 2023 | 1,072.00 |
| Mar 31, 2023 | -3,141.00 |
| Dec 31, 2022 | -3,532.00 |
| Sep 30, 2022 | 5,413.00 |
| Jun 30, 2022 | 5,597.00 |
| Mar 31, 2022 | 1,222.00 |
| Dec 31, 2021 | -2,863.00 |
| Sep 30, 2021 | -1,101.00 |